Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors

by Elizabeth A. Thomas
Published 2014-05-01

Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease

by Paula A. Desplats, James R. Lambert, Elizabeth A. Thomas
Published 2008-09-01

Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients

by Ashley Gutierrez, Jody Corey-Bloom, Elizabeth A. Thomas, Paula Desplats, Paula Desplats, Paula Desplats
Published 2020-01-01

Salivary levels of total huntingtin are elevated in Huntington’s disease patients

by Jody Corey-Bloom, Ameera S. Haque, Sungmee Park, Ajay S. Nathan, Robert W. Baker, Elizabeth A. Thomas
Published 2018-05-01

Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling.

by Bin Tang, Pietro Di Lena, Lana Schaffer, Steven R Head, Pierre Baldi, Elizabeth A Thomas
Published 2011-01-01

Effectiveness of Intermittent Fasting and Time-Restricted Feeding Compared to Continuous Energy Restriction for Weight Loss

by Corey A. Rynders, Elizabeth A. Thomas, Adnin Zaman, Zhaoxing Pan, Victoria A. Catenacci, Edward L. Melanson
Published 2019-10-01

Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington’s Patients

by Jody Corey-Bloom, Ameera Haque, Sameer Aboufadel, Chase Snell, Ryan S. Fischer, Steven W. Granger, Douglas A. Granger, Douglas A. Granger, Douglas A. Granger, Douglas A. Granger, Douglas A. Granger, Elizabeth A. Thomas, Elizabeth A. Thomas
Published 2020-03-01

Low density lipoprotein receptor-related protein and apolipoprotein E expression is altered in schizophrenia

by Andrew S Gibbons, Andrew S Gibbons, Elizabeth A Thomas, Elizabeth Scarr, Elizabeth Scarr, Brian Dean, Brian Dean, Brian Dean
Published 2010-07-01

Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease

by Bin Tang, Tamara Seredenina, Giovanni Coppola, Alexandre Kuhn, Daniel H. Geschwind, Ruth Luthi-Carter, Elizabeth A. Thomas
Published 2011-06-01

The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.

by Haiqun Jia, Ying Wang, Charles D Morris, Vincent Jacques, Joel M Gottesfeld, James R Rusche, Elizabeth A Thomas
Published 2016-01-01

Propensity to obesity impacts the neuronal response to energy imbalance

by Marc-Andre eCornier, Marc-Andre eCornier, Kristina Legget McFadden, Elizabeth A Thomas, Elizabeth A Thomas, Jamie L Bechtell, Jamie L Bechtell, Daniel H Bessesen, Daniel H Bessesen, Jason R Tregellas, Jason R Tregellas, Jason R Tregellas
Published 2015-02-01

Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington’s Disease Patients and Healthy Control Subjects

by Jody Corey-Bloom, Ryan S. Fischer, Aeri Kim, Chase Snell, Georgia M. Parkin, Douglas A. Granger, Steven W. Granger, Elizabeth A. Thomas
Published 2020-09-01

Glycolipid and ganglioside metabolism imbalances in Huntington's disease

by Paula A. Desplats, Christine A. Denny, Kristi E. Kass, Tim Gilmartin, Steven R. Head, J. Gregor Sutcliffe, Thomas N. Seyfried, Elizabeth A. Thomas
Published 2007-09-01

Later Meal and Sleep Timing Predicts Higher Percent Body Fat

by Elizabeth A. Thomas, Adnin Zaman, Marc-Andre Cornier, Victoria A. Catenacci, Emma J. Tussey, Laura Grau, Jaron Arbet, Josiane L. Broussard, Corey A. Rynders
Published 2021-12-01

A role of apolipoprotein D in triglyceride metabolism[S]

by German Perdomo, Dae Hyun Kim, Ting Zhang, Shen Qu, Elizabeth A. Thomas, Frederico G.S. Toledo, Sandra Slusher, Yong Fan, David E. Kelley, H. Henry Dong
Published 2010-06-01

Mindfulness-Oriented Recovery Enhancement Restructures Reward Processing and Promotes Interoceptive Awareness in Overweight Cancer Survivors: Mechanistic Results From a Stage 1 Ran...

by Elizabeth A. Thomas PhD, Jennifer L. Mijangos MSW, Pamela A. Hansen MD, Shelley White MSW, Darren Walker BS, Celestial Reimers RD, Anna C. Beck MD, Eric L. Garland PhD
Published 2019-06-01

Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease

by Haiqun Jia, Judit Pallos, Vincent Jacques, Alice Lau, Bin Tang, Andrew Cooper, Adeela Syed, Judith Purcell, Yi Chen, Shefali Sharma, Gavin R. Sangrey, Shayna B. Darnell, Heather Plasterer, Ghazaleh Sadri-Vakili, Joel M. Gottesfeld, Leslie M. Thompson, James R. Rusche, J. Lawrence Marsh, Elizabeth A. Thomas
Published 2012-05-01